[Funding alert] London-based Unfabled Secures €1.4 Million in Funding

London-based Unfabled secures €1.4 million in funding. The round will be used to grow the company's in-house data science, which is a vital component of its B2B offering, as well as the consumer-facing platform.

Morgan Stanley, Exceptional Ventures, Atomico Angels, Founders Factory, Chai Ventures, SyndicateRoom, and 3 Sisters Ventures were among the notable investors who participated in the seed round. A large proportion of female angel investors joined from the technology and healthcare sectors.

Read also - British Biotech FA Bio Raises €6.1 Million in Funding

Among them are Fiona Pathiraja, a philanthropist and healthcare investor, Elaine Groenestein, the first angel at Elvie, Shefali Roy (Apple, TrueLayer), and Maya Ghosn, a scout for Sequoia.

The business-to-business (B2B) component of Unfabled's product, its market intelligence platform, offers vital consumer behavior insights that enterprises and the healthcare industry may leverage to propel future improvements in women's health.

Read also - Dutch AI Startup Whispp Secures €750k in Seed Funding

Hannah Samano, Founder and CEO of Unfabled, said: “Despite 90% of the UK’s 33.8 million female population experiencing monthly hormonal symptoms, women’s health has for too long been fragmented and underserved. Unfabled has already empowered thousands of women to find effective treatments for common, yet hugely disruptive, hormonal and reproductive conditions like PMS, Polycystic Ovary Syndrome (PCOS), endometriosis and menopause.”

Samano claims that one of the main reasons for the gender health gap is the absence of data that is broken down by sex, which results in a lack of knowledge and comprehension regarding the health of women.

Read also - Lyon-based ENYO Pharma Secures a €39 Million in Series C Round Funding

Because of this, they are creating the most user-friendly platform they can while also bridging the enormous data gap in the health industry. The more knowledge they have on female health, the more intently they can work to improve it.

Sanghamitra Karra, Managing Director and EMEA Head of the Morgan Stanley Inclusive Ventures Group, added: “We have been impressed both by Unfabled’s platform and their reach, partnering with leading brands in the space. With an engaged community of 50,000 women and educational content on women’s health reaching 40M+ views, Hannah and the team’s proven organic-driven approach has enabled Unfabled to grow impressively since 2021.”

Matt Cooper, Co-Founder and Executive Chairman at Exceptional Ventures, also commented: “When investing in a company, our primary focus is finding businesses that match our vision of helping people to live happier, healthier and longer lives. At the same time, we’re looking for the most talented entrepreneurs capable of delivering on that vision. Unfabled was a clear fit on both points, we were instantly taken by its mission to support women’s hormonal health. Unabled’s data-led platform empowers women to discover products and services often overlooked by mainstream healthcare and provides a consumer-friendly solution to a long-standing problem that affects so many lives. Hannah is a brilliant founder whose intellect, passion and drive for her business and its mission were irresistible.”

About Unfable

Hannah Samano (formerly of Unilever and Kasha) founded Unfabled in 2021. It is a data-driven wellness platform that offers tailored and curated solutions for women. Users of Unfabled receive a carefully curated list of reliable and efficient products to fulfill their needs after responding to a series of questions regarding their priorities related to hormones and health.

Read also -  London-based Episode 1 Secures its Third Fund at £76 Million